Fatal BCG vaccination.

Z Erdös; J Romhányi; C Szemenyei

Home/Archive/PubMed

PubMed · 1030164

Fatal BCG vaccination.

Z Erdös·J Romhányi·C Szemenyei

View original source ↗Export metadata ↓

Abstract

A female baby 7 weeks of age developed a fatal tuberculous disease following BCG vaccination. The infant had Swiss type agammaglobulinaemia, associated with oral thrush, pneumonitis, umbilical infection and chronic enteritis not responding to any treatment. Post mortem revealed an aplasia of the thymus, hypoplasia of the lymph system, miliary tuberculous foci in the lymph nodes, liver and spleen.

Explore related subjects

Agammaglobulinemia BCG Vaccine Female Humans Infant Infant, Newborn Lymphoid Tissue Thymus Gland Tuberculosis, Miliary Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Z Erdös, J Romhányi, C Szemenyei. 1976. Fatal BCG vaccination.. https://pubmed.ncbi.nlm.nih.gov/1030164/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Secondary bronchiolitis obliterans organising pneumonia in a patient with carbamazepine-induced hypogammaglobulinemia.

Explore the source record for details and available documents.

Agammaglobulinemia↗

PubMed2006

Pneumocystis carinii pneumonia in an infant with hypogammaglobulinemia.

Explore the source record for details and available documents.

Agammaglobulinemia↗

PubMed2006

Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia.

The critical role of Bruton tyrosine kinase (Btk) in B cells has been documented by the block of B-cell development in X-linked agammaglobulinemia (XLA). Less is known about Btk function in myeloid cells. Several pieces of evidence indicate that Btk is a component of Toll-like receptor (TLR) signaling. We analyzed whether Btk deficiency in XLA is associated with an impaired dendritic cell (DC) compartment or defective TLR signaling. We analyzed the expression of TLRs 1 to 9 on myeloid DCs generated from XLA patients and evaluated their response to activation by specific TLR agonists. We show that XLA patients have normal numbers of circulating DCs. Btk-deficient DCs have no defect in response to stimulation of TLRs 1/2, 2/6, 3, 4, and 5 but display a profound impairment of IL-6 and TNF-alpha production in response to stimulation by TLR-8 cognate agonist, ssRNA. These findings may provide an explanation for the susceptibility to enteroviral infections in XLA patients.

Agammaglobulinemia↗